Tesamorelin cut deep belly fat by 15.2% in a large HIV study
Tesamorelin is a prescription drug with 1 approved use. This page covers how the drug acts, what studies found, and where proof stops.
What tesamorelin changes first
Tesamorelin copies a brain-made message that reaches the pea-sized gland under the brain. The gland puts growth hormone into your blood while the liver makes IGF-1 in reply. This liver-made hormone helps break down deep belly fat.
The largest study followed 412 adults with HIV-related fat buildup. Deep fat in their bellies dropped 15.2% with tesamorelin. It rose 5.0% with placebo [1]. A placebo was a look-alike shot without the drug.
Only this HIV use has FDA approval. The fat can return when treatment stops [2][6].
What tesamorelin changed in adults with HIV
Tesamorelin is a peptide, meaning a tiny chain of protein pieces. The chain carries 1 hormone message. An added piece helps the drug resist quick breakdown [1]. That gives the gland time to respond. Growth hormone reaches the blood in short bursts. The liver makes a related hormone called IGF-1. Together, the hormones help the body break down stored fat [4].
The main 26-week Phase 3 study followed 412 adults with HIV. This was a large, late test before approval. Each person received tesamorelin 2 mg per day or placebo. Deep belly fat fell 15.2% with the drug. It rose 5.0% with placebo. Triglycerides fell by 50 milligrams per deciliter. A deciliter means one-tenth of a liter of blood. The placebo result moved the other way [1]. After 52-week follow-up, deep fat stayed 18% below the start [2].
In 2026, a review joined the results from five studies. Adults lost deep belly, chest, and trunk fat. Their lean mass also rose slightly [13]. Lean mass means muscle, organs, bone, and body water. The review couldn't show that people became stronger or healthier.
All main benefit studies involved adults with HIV [1][2][6]. Deep fat came back when treatment ended [2][6]. The FDA hasn't approved another use. The FAQ covers side effects and health reasons to avoid it. It also answers whether tesamorelin is FDA approved.
The study limits matter as much as the results.
What helps the tesamorelin peptide stay active
The tesamorelin peptide is a tiny chain of protein pieces. It contains 44 pieces [1]. One added part shields the spot the body breaks first. That shield lets the drug stay active longer [4].
Tesamorelin isn't growth hormone. It tells the gland to release hormone already stored there.
The approved powder comes in a salt form [1], which joins the drug to a helper chemical. Drug makers do this to prepare and store the powder. It isn't table salt. Sermorelin is a shorter drug with a similar purpose. The tesamorelin and sermorelin comparison explains both drugs.
What tesamorelin changed and did not prove
The proven changes are narrow. They came from adults with HIV-related fat buildup. One study measured 15.2% less deep belly fat. Triglycerides fell 50 milligrams per deciliter [1]. These blood fats were counted by the deciliter, which means one-tenth of a liter. The study didn't prove that this drop prevented illness.
Across two Phase 3 studies, 543 people received tesamorelin. Another 263 received placebo. More people on tesamorelin got below 140 centimeters squared of deep fat. That is an area on one scan slice, not waist size. Researchers made a 95% range for where the true answer may fall. Even the lowest end still favored tesamorelin [10].
People who lost at least 8% of deep fat had better blood-fat tests [7]. A second review checked blood tests linked with inflammation, the body's response to harm. Those tests improved as deep fat fell [8]. The hormone rise didn't match the improvement as closely. The fat loss did.
Over 26 weeks, CT scans showed that the remaining fat became denser [9]. A CT scan is a detailed X-ray picture. Researchers called that better fat quality. They couldn't show that the scan change helped people feel better.
These studies can't predict your result. All participants had HIV-related fat buildup.
What tesamorelin is approved to treat
The approved use is narrow. In 2010, the United States approved tesamorelin for one purpose [5]. The drug may reduce extra belly fat tied to HIV medicine. Approval doesn't cover common weight loss, bodybuilding, or aging. Those uses are off-label, which means they lack FDA approval.
A federal review found no clear liver harm from tesamorelin [5]. Organized sports also ban the drug. In 2026, one paper found no sound proof for bone or joint care [15].
A research-only lab vial isn't the approved prescription medicine. Its strength and cleanliness may differ. It also lacks pharmacy checks, so it isn't meant for self-treatment.